Rekombinanter PDGFRA (Olaratumab Biosimilar) Antikörper (Biotin)
Kurzübersicht für Rekombinanter PDGFRA (Olaratumab Biosimilar) Antikörper (Biotin) (ABIN7829429)
Target
Antikörpertyp
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
Güteklasse
-
-
Verwendungszweck
- Biotinylated Anti-PDGFRA(olaratumab biosimilar) mAb
-
Isotyp
- IgG1, K214R, kappa
-
-
-
-
Kommentare
-
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Please see Certificate of Analysis for specific instructions of reconstitution.
-
Buffer
- Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.
-
Haltbarkeit
- 12 months
-
-
- PDGFRA (Olaratumab Biosimilar)
-
Andere Bezeichnung
- Olaratumab Biosimilar
-
Substanzklasse
- Biosimilar
-
Hintergrund
-
Synonyms Target:CD140A,PDGFR2,PDGFR-2
Synonyms Antibody:IMC-3G3,IMC 3G3,IMC3G3,Lartruvo,LY 3012207,LY-3012207,LY3012207 -
UniProt
- P16234
Target
-